Lindsey Trickett
Investor Relations Contact en F-STAR THERAPEUTICS, INC. .
Perfil
Lindsey Trickett is currently the Vice President of Investor Relations at Prelude Therapeutics, Inc. and the VP of Investor Relations & Communications at F-star Therapeutics, Inc. She previously worked as the Vice President of Investor Relations at Intellia Therapeutics, Inc. Ms. Trickett received an undergraduate degree from the University of Kentucky and an MBA from Georgetown University.
Cargos activos de Lindsey Trickett
| Empresas | Cargo | Inicio |
|---|---|---|
| F-STAR THERAPEUTICS, INC. | Investor Relations Contact | - |
| PRELUDE THERAPEUTICS INCORPORATED | Investor Relations Contact | - |
Antiguos cargos conocidos de Lindsey Trickett.
| Empresas | Cargo | Fin |
|---|---|---|
| INTELLIA THERAPEUTICS, INC. | Investor Relations Contact | - |
Formación de Lindsey Trickett.
| University of Kentucky | Undergraduate Degree |
| Georgetown University | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| INTELLIA THERAPEUTICS, INC. | Health Technology |
| PRELUDE THERAPEUTICS INCORPORATED | Health Technology |
| Empresas privadas | 1 |
|---|---|
F-star Therapeutics, Inc.
 F-star Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology F-star Therapeutics, Inc. is a clinical-stage immuno-oncology company. It focuses on transforming the lives of patients with cancer through the development of tetravalent mAb2 bispecific antibodies. The firm's product candidate, FS118, simultaneously targets two immune checkpoint receptors, LAG-3 and PD-L1, to directly address known tumor evasion pathways. The company was founded on October 7, 2002 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Lindsey Trickett
